Home › Endometriumkanker › Texas › Austin
Endometriumkanker klinische studies in Austin, TX
15 studies voor Endometriumkanker zoeken deelnemers op locaties in en rond Austin (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruterenFase 1/2
- New Experimental Therapeutics - NEXT Oncology, Austin
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RekruterenFase 1
- NEXT Austin, Austin
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RekruterenFase 1
- NEXT Oncology, Austin
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
RekruterenFase 3
- USOR - Texas Oncology, Austin
- USOR - Texas Oncology, Austin
- USOR - Texas Oncology- Austin North, Austin
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
RekruterenFase 3
- Research Site, Austin
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
RekruterenFase 1
- NEXT Austin, Austin
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
RekruterenFase 1
- NEXT Austin, Austin
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
RekruterenFase 1
- NEXT Oncology - Austin, Austin
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RekruterenFase 1/2
- Texas Oncology - Central / South Texas, Austin
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- Texas Oncology - Central/South Texas, Austin
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RekruterenFase 3
- Research Site, Austin
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
RekruterenFase 1
- NEXT Texas LLC - Austin, Austin
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Elligo Health Research, Inc., Austin
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RekruterenFase 1
- Dren Investigational Site, Austin
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
RekruterenFase 2/3
- Texas Oncology-Austin Central, Austin
Endometriumkanker studies in andere steden
- Houston, TX68 studies
- New York City, NY52 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN38 studies
- Los Angeles, CA34 studies
- St. Louis, MO29 studies
- Philadelphia, PA28 studies
- San Antonio, TX27 studies
- Chicago, IL25 studies
- Columbus, OH25 studies
- Queens, NY25 studies
Andere studies in Austin
- Niet-kleincellige longkanker30 studies
- Kanker (alle vormen)20 studies
- Obesitas20 studies
- Metastatische kanker19 studies
- Colorectale kanker19 studies
- Hartfalen18 studies
- Borstkanker18 studies
- Overgewicht18 studies
- Eierstokkanker17 studies
- Prostaatkanker15 studies
- Depressie14 studies
- Drievoudig negatieve borstkanker13 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.